News / Health

Improved TB Vaccine in Works as Global Infection Rates Fall

Children participate in the launch of a global plan to stop tuberculosis, in Alexandra Township, north of Johannesburg, South Africa, October 2010. (file photo)
Children participate in the launch of a global plan to stop tuberculosis, in Alexandra Township, north of Johannesburg, South Africa, October 2010. (file photo)
Gabe Joselow

With tuberculosis infection rates falling around the world, health officials are pressing to build on those gains. One project in development aims to create a better vaccine to stop the disease for good.

The latest World Health Organization report on tuberculosis shows the number of people contracting the disease fell to 8.8 million in 2010, down from nine million five years earlier. Most of those gains have been made in some of the worst-affected areas of East Africa - notably Kenya and Tanzania.

Better treatment is largely responsible for decreased infection rates. Medical officials are not just looking for ways to treat TB, however, but to prevent it altogether.  

Intensified vaccine initiative

There are several projects underway to create a more effective vaccine. The WHO says there are 10 top contenders being tested right now. One of them has been developed by the U.S.-based company Aeras.

“Our aim is to enroll 4,000 infants by the end of next year and hopefully we'll have a vaccine that works better than the current vaccine," said Vicky Cardenas, a clinical product director for Aeras, which currently is testing its new drug in five countries in Sub-Saharan Africa. "The current vaccine is called BCG and it's delivered at birth to infants, but it doesn't protect very well against pulmonary tuberculosis and it doesn't protect adults against tuberculosis.”


The current vaccine, BCG has been in use since 1921. Many of the treatments are at least 50 years old, and TB infections are becoming resistant to traditional medications. The new Aeras vaccine, known as Aeras-402, is in an advanced stage of its trial, and the company hopes to have a drug on the market by 2020.

Clinical trials in Kenya

Aeras is conducting clinical tests of the drug in the town of Kisumu in western Kenya at a clinic run by the Centers for Disease Control and the Kenya Medical Research Institute.

Cardenas said one of the reasons they chose Kenya for the trial is because of the country's influence in the region.

“What I was finding when I was working with Malaria vaccines is that most countries say, 'I'm not going to buy it unless you've tested it in my population.' So we have to overcome that barrier, because we obviously cannot test it in 192 countries," she said. "So what we like to do is to find countries that are like the opinion leaders for the region, and so Kenya, that's what we feel about Kenya, Kenya can lead the other countries."

Kenya also is an important testing ground because of the high risk that TB poses in to HIV-infected patients. The WHO says 41 percent of people infected with tuberculosis in Kenya also have HIV. The combination of the two diseases often is fatal.

Cross-treatment, funding

Grace Kiringa, a Kenyan doctor working on the Aeras vaccine project, said, “Of all the TB cases that we've found, about 22 percent of them were HIV infected. And yet, the HIV-infected babies are only like 60 out of a group of about 3,000 babies, yet they contribute 22 percent of the TB cases. So they're definitely at risk of contracting TB and actually, the sad thing is that most of them die before we can get the intervention to them."

According to WHO data, of the 22 so-called high-burden countries, where TB is most prevalent, nine are in Sub-Saharan Africa. South Africa is the worst-affected with 213,000 cases, followed by Kenya, with 97,000. Uganda, Tanzania and Ethiopia also are among the high-burden countries.

WHO says that while TB infection rates have dropped, the organization says more funding is still needed to extend treatment to more patients, particularly those with a drug-resistant strain of the disease.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid